The Journal of Korean Medicine (대한한의학회지)

The Society of Korean Medicine (대한한의학회)
권호 표지

Anti-inflammatory Effect of Gyulpidaehwangbakcho-tang (Jupidahuangpoxiao-tang) in the Collagen-induced Arthritis Mouse Model

  • Song, Young-Il (Department of Oriental Rehabilitation Medicine, College of Oriental Medicine, Daejeon University) ;
  • Oh, Min-Seok (Department of Oriental Rehabilitation Medicine, College of Oriental Medicine, Daejeon University)
  • Received : 2011.07.20
  • Accepted : 2011.09.07
  • Published : 2011.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: To investigate anti-inflammatory and anti-arthritic effects of Gyulpidaehwangbakcho-tang (GDBT) extract in a murine model of rheumatoid arthritis. Methods: The mice received $100{\mu}g$ of bovine type II collagen in Freund's complete adjuvant by intradermal injection at the base of the tail on day 0 and a booster injection on day 21. The mice were orally administered with GDBT (200 or 50mg/kg dissolved in distilled water) daily from day 1 to day 21 after arthritis incidence, and monitored for disease incidence and the severity of arthritis up to day 21. In order to evaluate the effect of GDBT on disease progression, we examined pro-inflammatory cytokines including IL-$1{\beta}$, IL-6, TNF-${\alpha}$, COX-2 and NOS-II. Results: GDBT produced a significant and dose dependent inhibition of arthritis and inflammation during the entire duration of the study. This action was characterized by the decreased production of IL-$1{\beta}$, IL-6, TNF-${\alpha}$, COX-2, and NOS-II in vivo. Conclusion: We believe that the anti-arthritic activity of GDBT is due to its modulatory effect on the expression of pro-inflammatory cytokine in the synovium. Our results contribute towards validation of the traditional use of GDBT in the treatment of RA and other inflammatory joint disorders.

Keywords

References

  1. Kvien TK, Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics. 2004; 22(2 Suppl 1):1-12.
  2. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell. 1996; 85:307-10. https://doi.org/10.1016/S0092-8674(00)81109-5
  3. Wolfe F, Hawley DJ. The long-term outcomes of rheumatoid arthritis: work disability: a prospective 18 year study of 823 patients. J Rheumatol. 1998; 25(11):2108-117.
  4. Fleischmann R, Stern R, Iqbal IA. An inhibitor of IL-1 for the treatment of rheumatoid arthritis. Expert Opin Biol Ther. 2004; 4(8):1333-44. https://doi.org/10.1517/14712598.4.8.1333
  5. Chandrashekara S, Anikumar T, Jamuna S. Complementary and alternative drug therapy in arthritis. J Assoc Physicians India. 2002; 50: 225-7.
  6. Yang YH, Rajaiah R, Lee DY. Ma Z, Yu HY, Fong HHS et al. Suppression of ongoing experimental arthritis by a Chinese herbal formula (huo-luo-xiao-lingdan) involves changes in antigeninduced immunological and biochemical mediators of inflammation. Evid Based Complement Alternat Med. 2010; 2011:1-10.
  7. Zhang ZJ. Synopsis of Prescriptions of the Golden Chamber (金匱要略). Beijing: Renmin weisheng Publishing Co. 1989:670.
  8. Lee WC. A Research on Clinical Use of the Xiexiafa (瀉下法). J Korean Oriental Med. 2000; 21(4):3-8.
  9. Lee SI, Hyun PM, Kim SH, Kim KS, Lee SK, Kim BS. Suppression of the onset and progression of collagen-induced arthritis by chebulagic acid screened from a Natural Product Library. Arthritis Rheum. 2005; 52(1):345-53. https://doi.org/10.1002/art.20715
  10. Lee YC, Kim SH, Roh SS, Choi HY, Seo YB.Suppressive effects of Chelidonium majus methanol extract in knee joint, regional lymph nodes, and spleen on collagen-induced arthritis in mice. J Ethnopharmacol. 2007; 112(1):40-8. https://doi.org/10.1016/j.jep.2007.01.033
  11. Kremer JM, Westhovens R, Leon M, Alten R, Steinfeld S, Russell A et al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. NEngl J Med. 2003; 349(20):1907-15. https://doi.org/10.1056/NEJMoa035075
  12. Wooley PH, Chapedelaine JM. Immunogenetics of collagen-induced arthritis. Crit Rev Immunol. 1987; 8(1):1-22.
  13. Luross JA, Williams NA. The genetic and immunopathological processes underlying collageninduced arthritis. Immunology. 2001; 103(4): 407-16. https://doi.org/10.1046/j.1365-2567.2001.01267.x
  14. Bensky D, Barolet R. Chinese herbal medicine: Formulas & Strategies. Seattle: Eastland Press. 1990:82-3.
  15. Bensky D, Gamble A. Chinese Herbal Medicine: Materia Medica. Revised edition. Seattle: Eastland Press. 1993:329-30
  16. Lee NK, Choi SH, Park SH, Park EK, Kim DH. Antiallergic activity of hesperidin is activated by intestinal microflora. Pharmacology. 2004; 71(4): 174-80. https://doi.org/10.1159/000078083
  17. Sasaki K, Yoshizaki F. Nobiletin as a tyrosinase inhibitor from the peel of Citrus fruit. Biol Pharm Bull. 2002; 25(6):806-8. https://doi.org/10.1248/bpb.25.806
  18. Kim YS, Jung EA, Shin JE. Chang JC, Yang HK, Kim NJ, et al. Daio-Orengedokuto inhibits HMGCoA reductase and pancreatic lipase. Biol Pharm Bull. 2002; 25(11):1442-5. https://doi.org/10.1248/bpb.25.1442
  19. Park EK, Choo MK, Yoon HK, Kim DH. Antithrombotic and antiallergic activities of rhaponticin from Rhei Rhizoma are activated by human intestinal bacteria. Arch Pharm Res. 2002; 25(4):528-33. https://doi.org/10.1007/BF02976613
  20. Kim IR, Kim HC, Kook YB, Park SJ, Park YG, Park JH, et al. Herbal medicine. Seoul: Younglimsa. 1994:244-5.
  21. Hwang CH, Byoun I. Study for international emergency medicine and medication: On stroke. Hyeahwa Med. 1994; 1(3):16-45.
  22. Zhang RX, Fan AY, Zhou AN, Moudgil KD, Ma ZZ, Lee DY, et al. Extract of the Chinese herbal formula Huo Luo Xiao Ling Dan inhibited adjuvant arthritis in rats. J Ethnopharmacol. 2009;121(3):366-71. https://doi.org/10.1016/j.jep.2008.11.018
  23. Janossy G, Panayi G, Duke O, Bofill M, Poulter LW, Goldstein G. Rheumatoid arthritis: a disease of T lymphocyte/macrophage immunoregulation. Lancet. 1981; 2(8251):839-42.
  24. Kadowaki KM, Matsuno H, Tsuji H, Tunru I. CD4+ T cells from collagen-induced arthritic mice are essential to transfer arthritis into severe combined immunodeficient mice. Clin Exp Immunol. 1994; 97(2):212-8.
  25. Williams RO, Whyte A, Waldmann H. Resistance to collagen induced arthritis in DBA/1 mice by intraperitoneal administration of soluble type II collagen involves both CD4+ and CD8+ T lymphocytes. Autoimmunity. 1989; 4(4):237-45. https://doi.org/10.3109/08916938909014700
  26. Gonzalez-Rey E, Chorny A, Varela N, O'Valle F, Delgado M. Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells. Arthritis Rheum. 2007; 56(2):531-43. https://doi.org/10.1002/art.22394
  27. Nguyen LT, Jacobs J, Mathis D, Benoist C. Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum. 2007; 56(2):509-20. https://doi.org/10.1002/art.22272
  28. Kang SM, Jang E, Paik DJ, Jang YJ, Youn J. CD4+CD25+ regulatory T cells selectively diminish systemic autoreactivity in arthritic K/BxN mice. Mol Cells. 2008; 25(1):64-9.
  29. Monte K, Wilson C, Shih FF. Increased number and function of FoxP3 regulatory T cells during experimental arthritis. Arthritis Rheum. 2008; 58(12):3730-41. https://doi.org/10.1002/art.24048
  30. Harris ED Jr. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med. 1990; 322(18):1277-89. https://doi.org/10.1056/NEJM199005033221805
  31. Jacques C, Gosset M, Berenbaum F, Gabay C. The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation. Vitam Horm. 2006; 74:371-403.
  32. Sack U, Kinne RW, Marx T, Heppt P, Bender S, Emmrich F. Interleukin-6 in synovial fluid is closely associated with chronic synovitis in rheumatoid arthritis. Rheumatol Int. 1993; 13(2): 45-51. https://doi.org/10.1007/BF00307733
  33. Madhok R, Crilly A, Watson J, Capell HA. Serum interleukin-6 levels in rheumatoid arthritis: correlation with clinical and laboratory indices of disease activity. Ann Rheum Dis. 1993; 52(3):232-4. https://doi.org/10.1136/ard.52.3.232
  34. Sasai M, Saeki Y, Ohshima S, Nishioka K, Mima T, Tanaka T, et al. Delayed onset and reduced severity of collagen-induced arthritis in interleukin- 6-deficient mice. Arthritis Rheum. 1999; 42(8): 1635-43. https://doi.org/10.1002/1529-0131(199908)42:8<1635::AID-ANR11>3.0.CO;2-Q
  35. Hata H, Sakaguchi N, Yoshitomi H, Iwakura Y, Sekikawa K, Azuma Y, et al. Distinct contribution of IL-6, TNE-alpha, IL-1 and IL-10 to T cellmediated spontaneous autoimmune arthritis in mice. J ClinInvest. 2004; 114(4):582-8.
  36. Cannon GW, Openshaw SJ, Hibbs Jr JB, Hoidal JR, Huecksteadt TP, Griffiths MM. Nitric oxide production during adjuvant-induced and collageninduced arthritis. Arthritis Rheum. 1996; 39(10): 1677-84. https://doi.org/10.1002/art.1780391010
  37. Myers LK, Kang AH, Postlethwaite AE, Rosloniec EF, Morham SG, Shlopov BV, et al. The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. Arthritis Rheum. 2000; 43(12):2687-93. https://doi.org/10.1002/1529-0131(200012)43:12<2687::AID-ANR8>3.0.CO;2-9
  38. Bauerova K, Bezek A. Role of reactive oxygen and nitrogen species in etiopathogenesis of rheumatoid arthritis. Gen Physiol Biophys. 1999; 18:15-20.
  39. Siegle I, Klein T, Backman JT, Saal JG, Nusing RM, Fritz P. Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases. Arthritis Rheum. 1998; 41(1):122-9. https://doi.org/10.1002/1529-0131(199801)41:1<122::AID-ART15>3.0.CO;2-8
  40. Sano H, Hla T, Maier JA, Crofford LJ, Case JP, Maciag T, et al. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest. 1992; 89(1):97-108. https://doi.org/10.1172/JCI115591